Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
The primary goal of this study will be to explore the reparative and regenerative potential
 of alemtuzumab in RRMS patients who are participating in the CARE MS I and CARE MS II studies
 using conventional and non-conventional MRI sequences.
Inclusion Criteria:

 -  Participating in either the CARE MS I or CARE MS II studies

 Exclusion Criteria:

 -  Not a participant in the CARE MS I or CARE MS II studies